Healthcare -
Biotechnology - NASDAQ - US
$ 46.52
-0.853 %
$ 1.78 B
Market Cap
-12.41
P/E
TARS - TOTAL RECEIVABLES
Total Receivables TARS - Tarsus Pharmaceuticals, Inc.
17.7 M
LAST VALUE
1287.60%
2 YEAR CAGR
436.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR